Javascript must be enabled to continue!
Clinical effects of hyperbaric oxygen therapy on paroxysmal sympathetic hyperactivity after cardiopulmonary resuscitation: a case series
View through CrossRef
Abstract
Background
After cardiopulmonary resuscitation (CPR), paroxysmal sympathetic hyperactivity (PSH) will appear due to extensive brain injury. PSH is a serious clinical syndrome, and it is often treated with drugs. However, the application of hyperbaric oxygen in the treatment(HBOT) of PSH is rarely reported in the literature.We aimed to investigate the clinical effects of single-chamber pure oxygen treatment on PSH following CPR.
Methods
We retrospectively analysed clinical data of four patients treated at our hospital who developed signs of PSH post-CPR and received HBOT at an early stage to assess the clinical effects of HBOT on PSH.
Results
Following 3–4 HBOT sessions, signs of PSH were substantially diminished, and patients’ Clinical Symptom Scale scores decreased significantly. The time to awakening was 34, 25, 38, and 28 days for cases 1–4, respectively.
Conclusions
HBOT alleviated PSH, reduced brain damage, and promoted a return to full consciousness. HBOT efficacy was significant in these patients, and promoting HBOT in the clinical setting is recommended.
Title: Clinical effects of hyperbaric oxygen therapy on paroxysmal sympathetic hyperactivity after cardiopulmonary resuscitation: a case series
Description:
Abstract
Background
After cardiopulmonary resuscitation (CPR), paroxysmal sympathetic hyperactivity (PSH) will appear due to extensive brain injury.
PSH is a serious clinical syndrome, and it is often treated with drugs.
However, the application of hyperbaric oxygen in the treatment(HBOT) of PSH is rarely reported in the literature.
We aimed to investigate the clinical effects of single-chamber pure oxygen treatment on PSH following CPR.
Methods
We retrospectively analysed clinical data of four patients treated at our hospital who developed signs of PSH post-CPR and received HBOT at an early stage to assess the clinical effects of HBOT on PSH.
Results
Following 3–4 HBOT sessions, signs of PSH were substantially diminished, and patients’ Clinical Symptom Scale scores decreased significantly.
The time to awakening was 34, 25, 38, and 28 days for cases 1–4, respectively.
Conclusions
HBOT alleviated PSH, reduced brain damage, and promoted a return to full consciousness.
HBOT efficacy was significant in these patients, and promoting HBOT in the clinical setting is recommended.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Hyperbaric Oxygen Therapy for Sudden Sensorineural Hearing Loss – A Comorbidity Lens
Hyperbaric Oxygen Therapy for Sudden Sensorineural Hearing Loss – A Comorbidity Lens
Leder Macek AJ, Wang RS, Cottrell J, Kay-Rivest E, McMenomey SO, Roland Jr. T, Ross FL. Hyperbaric Oxygen Therapy for Sudden Sensorineural Hearing Loss – A Comorbidity Lens. Unders...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
High Concentration Oxygen and Hypercapnia in Respiratory Disease
High Concentration Oxygen and Hypercapnia in Respiratory Disease
<p>Oxygen-induced elevations in arterial carbon dioxide tension have been demonstrated in patients with chronic obstructive pulmonary disease (COPD), asthma, pneumonia, obesi...
Hyperbaric oxygen but not hyperbaric air increases insulin sensitivity in men with type 2 diabetes mellitus
Hyperbaric oxygen but not hyperbaric air increases insulin sensitivity in men with type 2 diabetes mellitus
(Wilkinson DC, Chapman IM, Heilbronn LK. Hyperbaric oxygen but not hyperbaric air increases insulin sensitivity in men with type 2 diabetes mellitus. Diving and Hyperbaric Medicine...
EPD Electronic Pathogen Detection v1
EPD Electronic Pathogen Detection v1
Electronic pathogen detection (EPD) is a non - invasive, rapid, affordable, point- of- care test, for Covid 19 resulting from infection with SARS-CoV-2 virus. EPD scanning techno...
Hyperbaric medicine simulation education curriculum: CNS toxicity during Treatment Table 6 and intubated ICU patient with mucous plugging
Hyperbaric medicine simulation education curriculum: CNS toxicity during Treatment Table 6 and intubated ICU patient with mucous plugging
Introduction/Background: The incidence of complications and number of critically ill patients in hyperbaric medicine is relatively low [1]. This poses a challenge to those tasked w...
Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls
Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls
Objective: Given the high mortality and prolonged duration of mechanical ventilation of COVID-19 patients, we evaluated the safety and efficacy of hyperbaric oxygen for COVID-19 pa...

